Qiagen refinances 2021 convert with new $500m bond

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Equity
Equity-Linked

Qiagen refinances 2021 convert with new $500m bond

Aidan Gregory
December 10, 2020 12:45 PM
Qiagen_PA_575_375
08 September 2020, North Rhine-Westphalia, Hilden: Employees work in protective suits in a laboratory of the biotech company Qiagen. With financial support from the state of North Rhine-Westphalia, the biotech company Qiagen is expanding its production capacities for corona tests at its Hilden site near Düsseldorf. Qiagen will receive 18.3 million euros for the expansion of its laboratory diagnostics production facilities. Photo: Fabian Strauch/dpa | Fabian Strauch/DPA/PA Images

Qiagen, the Dutch diagnostics company, has launched the sale of a new convertible bond to refinance the unwinding of an older bond, set to mature in 2021.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

GermanyHealth and BiotechThe NetherlandsEquityEuropeEMEASRIEquity-Linked
AG
Aidan Gregory
Gift this article